Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-10-13

Clinical Trial Update: Zonisamide Treatment of Alcohol Use Disorder: an Evaluation of Efficacy and Mechanism of Action [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating zonisamide for alcohol use disorder has completed; results posted in 2022 with data on efficacy and mechanism of action.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Zonisamide (zonisamide)

Snippet

Sponsor: Virginia Commonwealth University | Conditions: Alcohol Use Disorder | Phase 3 | Status: COMPLETED | Results posted: 2022-10-13